InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Shafer Bradford J, Directeur Exécutif. Director active across 1 companies, notably Theravance Biopharma, Inc.. Cumulatively, 4 reports have been recorded. The latest transaction was disclosed on 20 August 2021 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations4 total
€51,8244,307 shares@ €12.03260.0062% mcap45.2% of flow
Ordinary Shares
SEC:0001179110-21-008402·
€51,8244,307 shares@ €12.03260.0062% mcap22.6% of flow
Ordinary Shares
SEC:0001179110-21-008402:0·
€62,7534,310 shares@ €14.55990.0075% mcap54.8% of flow
Ordinary Shares
SEC:0001179110-21-005850·
€62,7534,310 shares@ €14.55990.0075% mcap27.4% of flow
Ordinary Shares
SEC:0001179110-21-005850:0·
4 of 4 declarations
About Shafer Bradford J
Bradford J. Shafer serves as Executive Vice President, General Counsel, and Secretary at Theravance Biopharma, Inc. He oversees the legal affairs and compliance of the company, which focuses on drug development. Bradford J. Shafer plays a key role in managing legal risks and protecting the company's interests.
